Back to overview

Doctor visit report / sample data

GLP-1 journey summary

This sample demonstrates the first paid web wedge. It uses demo data and is not medical advice.

Date range
Feb 12 - May 6
Shots logged
12
Current dose
0.50 mg
Progress logs
8
Visit summary

Discussion-ready overview

Across the sample period, the user moved from a starter dose to a higher weekly dose and logged repeated mild nausea near shot day. Progress entries suggest a gradual weight trend, but the report should frame this as personal tracking context, not an expected outcome.

Timeline

Treatment events and notes

Week 01
Started weekly semaglutide routine at 0.25 mg. No side-effect entries recorded in the first week.
Week 05
Moved to 0.50 mg. Mild nausea and low appetite were logged within 24-36 hours after shot day.
Week 08
Two progress entries were added. Weight trend moved gradually down across the sample period.
Week 11
User added appointment notes asking whether symptom timing should be discussed before the next dose change.
Progress trend

What changed during this period?

The visual readout is designed to summarize movement over time while keeping the wording cautious and clinician-friendly.

Weight trend / sample
Questions for visit

What the user may want to discuss

"I noticed nausea tends to appear after shot day. Should I track anything else before my next appointment?"